SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    M. Shah, A. Shankar, I. Gee, K. Nash, M. Hoare, P. Gibbs, S. Davies, G. J. M. Alexander, A retrospective 15-year review: survival advantage after switching to sirolimus in hepatitis C virus infected liver graft recipients, Alimentary Pharmacology & Therapeutics, 2015, 41, 4
  2. 2
    A. Weick, W. Chacra, A. Kuchipudi, M. Elbatta, G. Divine, C. Burmeister, D. Moonka, Incidence of Cardiovascular and Cerebrovascular Events Associated With Sirolimus Use After Liver Transplantation, Transplantation Proceedings, 2015, 47, 2, 460

    CrossRef

  3. 3
    Phuong-Thu T. Pham, Chong Parke, Reza Allamezadeh, Phuong-Chi T. Pham, Gabriel M. Danovitch, Transplantation of the Liver, 2015,

    CrossRef

  4. 4
    Paige M. Porrett, Sohaib K. Hashmi, Abraham Shaked, Immunosuppression, Clinics in Liver Disease, 2014, 18, 3, 687

    CrossRef

  5. 5
    Liliane Lins, Jorge Bastos, Oral health protocol for liver transplant patients, Transplantation Technology, 2014, 2, 1, 2

    CrossRef

  6. 6
    Goran B. Klintmalm, Björn Nashan, The Role of mTOR Inhibitors in Liver Transplantation: Reviewing the Evidence, Journal of Transplantation, 2014, 2014, 1

    CrossRef

  7. 7
    Lewis Teperman, Dilip Moonka, Anthony Sebastian, Linda Sher, Paul Marotta, Christopher Marsh, Baburao Koneru, John Goss, Dennis Preston, John P. Roberts, Calcineurin Inhibitor–Free Mycophenolate Mofetil/Sirolimus Maintenance in Liver Transplantation: The Randomized Spare-the-Nephron Trial, Liver Transplantation, 2013, 19, 7
  8. 8
    Josh Levitsky, James M. Mathew, Michael Abecassis, Anat Tambur, Joseph Leventhal, Dhivya Chandrasekaran, Nancy Herrera, Patrice Al-Saden, Lorenzo Gallon, Anmaar Abdul-Nabi, Guang-Yu Yang, Sunil M. Kurian, Daniel R. Salomon, Joshua Miller, Systemic immunoregulatory and proteogenomic effects of tacrolimus to sirolimus conversion in liver transplant recipients, Hepatology, 2013, 57, 1
  9. 9
    T.M. Manzia, D. Sforza, R. Angelico, M.I. Bellini, P. Ciano, M. Manuelli, L. Toti, G. Tisone, Everolimus and Enteric-Coated Mycophenolate Sodium Ab Initio after Liver Transplantation: Midterm Results, Transplantation Proceedings, 2012, 44, 7, 1942

    CrossRef

  10. 10
    Siddharth Singh, Kymberly D. Watt, Long-term Medical Management of the Liver Transplant Recipient: What the Primary Care Physician Needs to Know, Mayo Clinic Proceedings, 2012, 87, 8, 779

    CrossRef

  11. 11
    Kieron B. L. Lim, Thomas D. Schiano, Long-Term Outcome After Liver Transplantation, Mount Sinai Journal of Medicine: A Journal of Translational and Personalized Medicine, 2012, 79, 2
  12. 12
    E.L.D. de Mare-Bredemeijer, H.J. Metselaar, Optimization of the use of Calcineurin inhibitors in liver transplantation, Best Practice & Research Clinical Gastroenterology, 2012, 26, 1, 85

    CrossRef

  13. 13
    Hani M. Wadei, Ziad S. Zaky, Andrew P. Keaveny, Barry Rosser, Melanie Jones, Martin L. Mai, Ilynn Bulatao, Thomas A. Gonwa, Proteinuria Following Sirolimus Conversion is Associated With Deterioration of Kidney Function in Liver Transplant Recipients, Transplantation Journal, 2012, 93, 10, 1006

    CrossRef

  14. 14
    C.H.P. Reigada, E.C. de Ataide, F.R. de Araújo, A.P. Ramos, R.S.B. Stucchi, C.A.F. Eescanhoela, I.F.S.F. Boin, Sirolimus as Rescue Therapy After Liver Transplantation, Transplantation Proceedings, 2012, 44, 8, 2434

    CrossRef

  15. 15
    Yasunobu Matsuda, Takafumi Ichida, Manabu Fukumoto, Hepatocellular carcinoma and liver transplantation: clinical perspective on molecular targeted strategies, Medical Molecular Morphology, 2011, 44, 3, 117

    CrossRef

  16. 16
    C. Duvoux, G.P. Pageaux, Immunosuppression in liver transplant recipients with renal impairment, Journal of Hepatology, 2011, 54, 5, 1041

    CrossRef

  17. 17
    Toshiyasu Kawahara, Sonal Asthana, Norman M. Kneteman, m-TOR inhibitors: What role in liver transplantation?, Journal of Hepatology, 2011, 55, 6, 1441

    CrossRef

  18. 18
    Marcelo Cantarovich, Nigel W. Brown, Mary H.H. Ensom, Ashok Jain, Dirk R.J. Kuypers, Teun Van Gelder, J. Michael Tredger, Mycophenolate monitoring in liver, thoracic, pancreas, and small bowel transplantation: a consensus report, Transplantation Reviews, 2011, 25, 2, 65

    CrossRef

  19. 19
    Maria-Sole Basso, Pushpa Subramaniam, Mike Tredger, Anita Verma, Nigel Heaton, Mohamed Rela, Giorgina Mieli-Vergani, Anil Dhawan, Sirolimus as renal and immunological rescue agent in pediatric liver transplant recipients, Pediatric Transplantation, 2011, 15, 7
  20. 20
    Simon J. F. Harper, William Gelson, Ines G. Harper, Graeme J. M. Alexander, Paul Gibbs, Switching to Sirolimus-Based Immune Suppression After Liver Transplantation Is Safe and Effective: A Single-Center Experience, Transplantation, 2011, 91, 1, 128

    CrossRef

  21. 21
    Mélanie Vallin, Olivier Guillaud, Isabelle Morard, Marie-Claude Gagnieu, Gilles Mentha, Mustapha Adham, Emmanuel Morelon, Olivier Boillot, Emiliano Giostra, Jérôme Dumortier, Tolerability of everolimus-based immunosuppression in maintenance liver transplant recipients, Clinical Transplantation, 2011, 25, 4
  22. 22
    Philipp Dutkowski, Olivier De Rougemont, Beat Müllhaupt, Pierre—Alain Clavien, Current and Future Trends in Liver Transplantation in Europe, Gastroenterology, 2010, 138, 3, 802

    CrossRef

  23. 23
    M. Masetti, R. Montalti, G. Rompianesi, M. Codeluppi, R. Gerring, A. Romano, B. Begliomini, F. Di Benedetto, G. E. Gerunda, Early Withdrawal of Calcineurin Inhibitors and Everolimus Monotherapy in de novo Liver Transplant Recipients Preserves Renal Function, American Journal of Transplantation, 2010, 10, 10
  24. 24
    Jörg Schrader, Martina Sterneck, Hans Klose, Ansgar W. Lohse, Björn Nashan, Lutz Fischer, Everolimus-induced pneumonitis: report of the first case in a liver transplant recipient and review of treatment options, Transplant International, 2010, 23, 1
  25. 25
    J. Dumortier, O. Guillaud, G. Pittau, J. Salandre, M. Adham, J.-Y. Scoazec, O. Boillot, Introduction of Mycophenolate Mofetil in Maintenance Liver Transplant Recipients: What Can We Expect? Results of a 10-Year Experience, Transplantation Proceedings, 2010, 42, 7, 2602

    CrossRef

  26. 26
    M. Vivarelli, A. Dazzi, A. Cucchetti, A. Gasbarrini, M. Zanello, P. Di Gioia, G. Bianchi, M.R. Tamè, M.D. Gaudio, M. Ravaioli, M. Cescon, G.L. Grazi, A.D. Pinna, Sirolimus in Liver Transplant Recipients: A Large Single-Center Experience, Transplantation Proceedings, 2010, 42, 7, 2579

    CrossRef

  27. 27
    Christian Toso, Seema Patel, Sonal Asthana, Toshiyasu Kawahara, Safwat Girgis, Norman N. Kneteman, A.M. James Shapiro, David L. Bigam, The impact of sirolimus on hepatocyte proliferation after living donor liver transplantation, Clinical Transplantation, 2010, 24, 5
  28. 28
    Paolo De Simone, Paola Carrai, Arianna Precisi, Stefania Petruccelli, Lidiana Baldoni, Emanuele Balzano, Juri Ducci, Francesco Caneschi, Laura Coletti, Daniela Campani, Franco Filipponi, Conversion to everolimus monotherapy in maintenance liver transplantation: feasibility, safety, and impact on renal function, Transplant International, 2009, 22, 3
  29. 29
    Burcin Ekser, Lucrezia Furian, Nicola Baldan, Alessandra Amico, Luca Fabris, Manuela Lazzarin, Francesco Marchini, Paolo Rigotti, Dual kidney transplantation after liver transplantation: a good option to rescue a patient from dialysis, Clinical Transplantation, 2009, 23, 1
  30. 30
    Adrian Liew, Gilbert S. C. Chiang, Anantharaman Vathsala, Factors associated with proteinuria in renal transplant recipients treated with sirolimus, Transplant International, 2009, 22, 3
  31. 31
    Yvon Calmus, Immunosuppression après transplantation hépatique, La Presse Médicale, 2009, 38, 9, 1307

    CrossRef

  32. 32
    Michael R. Charlton, William J. Wall, Akinlolu O. Ojo, Pere Ginés, Stephen Textor, Fuad S. Shihab, Paul Marotta, Marcelo Cantarovich, James D. Eason, Russell H. Wiesner, Michael A. Ramsay, Juan C. Garcia-Valdecasas, James M. Neuberger, Sandy Feng, Connie L. Davis, Thomas A. Gonwa, Report of the first international liver transplantation society expert panel consensus conference on renal insufficiency in liver transplantation, Liver Transplantation, 2009, 15, 11
  33. 33
    Anthony P. Monaco, The Role of mTOR Inhibitors in the Management of Posttransplant Malignancy, Transplantation, 2009, 87, 2, 157

    CrossRef

  34. 34
    Christin C. Rogers, Scott R. Johnson, Didier A. Mandelbrot, Martha Pavlakis, Timothy Horwedel, Seth J. Karp, Ogo Egbuna, James R. Rodrigue, Robyn E. Chudzinski, Alexander S. Goldfarb-Rumyantzev, Douglas W. Hanto, Michael P. Curry, Timing of sirolimus conversion influences recovery of renal function in liver transplant recipients, Clinical Transplantation, 2009, 23, 6
  35. 35
    Xiao-jun ZHANG, Application of sirolimus in patients with renal injury after liver transplantation, Academic Journal of Second Military Medical University, 2008, 28, 4, 461

    CrossRef

  36. 36
    C.P. Strassburg, M.J. Bahr, T. Becker, J. Klempnauer, M.P. Manns, Fortschritte in der Immunsuppression, Der Chirurg, 2008, 79, 2, 149

    CrossRef

  37. 37
    Kaheita Kakinoki, Shuichi Kaneko, Management of the Liver Transplant Recipients in the Stable-Phase, Kanzo, 2008, 49, 8, 339

    CrossRef

  38. 38
    Ana Moreno, Rafael Bárcena, Carmen Quereda, José L Casado, María J Pérez-Elías, Jesús Fortún, Javier Nuño, Isabel Arranz, Santiago Moreno, Safe use of raltegravir and sirolimus in an HIV-infected patient with renal impairment after orthotopic liver transplantation, AIDS, 2008, 22, 4, 547

    CrossRef

  39. 39
    A. Moreno, R. Bárcena, M. García-Gonzalez, F. García-Hoz, C. Quereda, J.L. Casado, M.J. Pérez-Elías, J. Fortún, J. Nuño, I. Arranz, S. Moreno, Severe Sirolimus-Related Inflammatory State Anemia in an HIV+ Liver Transplant Patient With Calcineurin Inhibitor Renal Insufficiency: A Case Report, Transplantation Proceedings, 2008, 40, 10, 3810

    CrossRef

  40. 40
    Geoffrey S. Jensen, Alexander Wiseman, James F. Trotter, Sirolimus conversion for renal preservation in liver transplantation: Not so fast, Liver Transplantation, 2008, 14, 5
  41. 41
    Derek DuBay, Rob J. Smith, Kenneth G. Qiu, Gary A. Levy, Leslie Lilly, George Therapondos, Sirolimus in liver transplant recipients with renal dysfunction offers no advantage over low-dose calcineurin inhibitor regimens, Liver Transplantation, 2008, 14, 5
  42. 42
    Savitha Subramanian, Dace L. Trence, Immunosuppressive Agents: Effects on Glucose and Lipid Metabolism, Endocrinology and Metabolism Clinics of North America, 2007, 36, 4, 891

    CrossRef

  43. 43
    Jennifer Kim, Eric Huang, Linda Sher, Jose L Almeda, The role of sirolimus in liver transplantation, Current Opinion in Organ Transplantation, 2007, 12, 6, 636

    CrossRef

  44. 44
    James F. Trotter, Rejection and Immunosuppression Trends in Liver Transplantation,